Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Janux Therapeutics

JANXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Janux Therapeutics (JANX) Forecast

News

Earnings Janux Therapeutics (JANX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Janux Therapeutics (NASDAQ:JANX) Stock

Janux Therapeutics Stock (NASDAQ: JANX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, December 11, 2024

Navigating 10 Analyst Ratings For Janux Therapeutics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Sunday, December 08, 2024

SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Lekha Gupta

Thursday, December 05, 2024

Reported Earlier, Janux Therapeutics Prices $...
Benzinga Newsdesk

Wednesday, December 04, 2024

Janux Therapeutics shares are trading higher ...
Benzinga Newsdesk
Scotiabank Maintains Sector Perform on Janux ...
Benzinga Newsdesk

Tuesday, December 03, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Janux Therapeutics Commences Underwritten Pub...
Benzinga Newsdesk
Stifel Maintains Buy on Janux Therapeutics, R...
Benzinga Newsdesk
Leerink Partners Maintains Outperform on Janu...
Benzinga Newsdesk
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Vandana Singh
AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Janux Therapeutics shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Janux Th...
Benzinga Newsdesk
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Monday, December 02, 2024

Janux shares are trading higher after it anno...
Benzinga Newsdesk
Janux Announced Updated Interim Clinical Data...
Benzinga Newsdesk

Monday, November 25, 2024

Janux Therapeutics To Host Virtual Event On M...
Benzinga Newsdesk

Friday, November 22, 2024

Evaluating Janux Therapeutics: Insights From 6 Financial Analysts
Benzinga Insights
Leerink Partners Initiates Coverage On Janux ...
Benzinga Newsdesk

Tuesday, November 12, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights

Thursday, November 07, 2024

HC Wainwright & Co. Reiterates Buy on Janux T...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Wednesday, November 06, 2024

Janux Therapeutics Q3 EPS $(0.51) Misses $(0....
Benzinga Newsdesk

Thursday, October 24, 2024

Cracking The Code: Understanding Analyst Reviews For Janux Therapeutics
Benzinga Insights
UBS Initiates Coverage On Janux Therapeutics ...
Benzinga Newsdesk

Monday, September 16, 2024

Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Friday, September 06, 2024

Navigating 5 Analyst Ratings For Janux Therapeutics
Benzinga Insights
Stifel Initiates Coverage On Janux Therapeuti...
Benzinga Newsdesk

Monday, August 19, 2024

HC Wainwright & Co. Reiterates Buy on Janux T...
Benzinga Newsdesk

Friday, August 09, 2024

Analyst Expectations For Janux Therapeutics's Future
Benzinga Insights
Scotiabank Maintains Sector Perform on Janux ...
Benzinga Newsdesk

Thursday, August 08, 2024

Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Janux Therap...
Benzinga Newsdesk

Wednesday, August 07, 2024

Janux Therapeutics Q2 EPS $(0.11) Beats $(0.3...
Benzinga Newsdesk

Friday, August 02, 2024

GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Michael Juliano

Monday, July 22, 2024

Janux Therapeutics Reports Appointment Of Cur...
Benzinga Newsdesk

Tuesday, July 16, 2024

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor

Friday, May 31, 2024

Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
Avi Kapoor

Thursday, May 30, 2024

The Latest Analyst Ratings For Janux Therapeutics
Benzinga Insights
Scotiabank Initiates Coverage On Janux Therap...
Benzinga Newsdesk

Monday, May 13, 2024

Analyst Ratings For Janux Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Janux Th...
Benzinga Newsdesk

Thursday, May 09, 2024

Janux Therapeutics shares are trading lower a...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Wednesday, May 08, 2024

Janux Therapeutics shares are trading lower a...
Benzinga Newsdesk
Janux Therapeutics Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Wedbush Maintains Outperform on Janux Therape...
Benzinga Newsdesk
Janux Therapeutics Inc Files For Mixed Shelf;...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved